基本信息
views: 158
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
As C-Level Executive and Chief Medical Officer in the pharmaceutical industry with a profound medical backround in Anesthesiology and Intensive Care Medicine, I provide pragmatic solutions by harmonizing business challenges with medical needs.
My expertise and 25-years experience in Healthcare and global Life Sciences include but are not restricted to:
- Extensive knowledge in Perioperative Medicine, Pharma, Nutrition, and MedTech
- Strategy development and execution
- Process optimization
- Financial planning and steering
- Medical innovation management (7 patents) coupled with a growth mindset
- Leadership in functionally and culturally diverse teams
- Organizational transformation to create high-performance teams
- Change management
- Preclincal drug development & clinical phase I-IV studies
- Safety in clinical trials, data management and statistics
- Medical-scientific affairs including training and education, global event planning and execution
- Regulatory affairs including interactions with regulatory authorities on a global scale
- Strategic understanding of the ongoing global digitization
- Product registration and launch
- Pharmacovigilance deferral procedures
- Key opinion leader (KOL) management
- Solution-oriented business coaching
- Negotiation skills targeting to create win-win situations
- Due diligence
- Sustainability
- Clinical education in Anesthesiology and Intensive Care Medicine
- Team lead in diverse clinical disciplines and ICU
- Medical writing and publishing (200+ peer-reviewed publications)
My expertise and 25-years experience in Healthcare and global Life Sciences include but are not restricted to:
- Extensive knowledge in Perioperative Medicine, Pharma, Nutrition, and MedTech
- Strategy development and execution
- Process optimization
- Financial planning and steering
- Medical innovation management (7 patents) coupled with a growth mindset
- Leadership in functionally and culturally diverse teams
- Organizational transformation to create high-performance teams
- Change management
- Preclincal drug development & clinical phase I-IV studies
- Safety in clinical trials, data management and statistics
- Medical-scientific affairs including training and education, global event planning and execution
- Regulatory affairs including interactions with regulatory authorities on a global scale
- Strategic understanding of the ongoing global digitization
- Product registration and launch
- Pharmacovigilance deferral procedures
- Key opinion leader (KOL) management
- Solution-oriented business coaching
- Negotiation skills targeting to create win-win situations
- Due diligence
- Sustainability
- Clinical education in Anesthesiology and Intensive Care Medicine
- Team lead in diverse clinical disciplines and ICU
- Medical writing and publishing (200+ peer-reviewed publications)
Research Interests
Papers共 316 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Valentin Faerber, Katharina S. Kuhn,Liliana Garneata,Kamyar Kalantar-Zadeh,Sahir Kalim,Dominic S. Raj,Martin Westphal
NUTRIENTSno. 16 (2023): 3503-3503
JOURNAL OF SURGICAL RESEARCH (2023): 1-12
Anästhesie Nachrichtenno. 3 (2022): 211-213
Katharina Thomas,Lisa Zondler,Nadine Ludwig,Marina Kardell, Corinna Lüneburg, Katharina Henke,Sina Mersmann,Andreas Margraf,Tilmann Spieker,Tobias Tekath,Ana Velic,Richard Holtmeier,
Clementina Duran Palma,Musawenkosi Mamba,Johan Geldenhuys,Oluwafolajimi Fadahun,Rolf Rossaint, Kai Zacharowski, Martin Brand,Óscar Díaz-Cambronero,Javier Belda,Martin Westphal,Ute Brauer, Dirk Dormann,
Tim Kampmeier, Sebastian Rehberg,Abdul Jabbar Omar Alsaleh,Stefan Schraag, Jenny Pham,Martin Westphal
British journal of anaesthesiano. 6 (2020): 847-849
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn